Company attributes
B2X
CEO
Founder
Pitchbook URL
Number of Employees (Ranges)
1 – 10
Email Address
info@immunitastx.com0
Full Address
830 Winter St., 2nd floor Waltham, MA 024510
Investors
Total Funding Amount (USD)
97,000,000
Latest Funding Round Date
August 19, 2021
Former CEO
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
58,000,000
Immunitas Therapeutics is a company that is developing immunology through single-cell analysis for patients with complex or complicated cancer diagnoses. The company is identifying and developing key biomarkers to assist in the selection of "ideal" patients for clinical drug trials.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
